Medical Devices & Consumables
Global Blood-Gas Exchanger Market Research Report 2026
- Nov 14, 26
- ID: 760826
- Pages: 119
- Figures: 120
- Views: 20
The global Blood-Gas Exchanger market was valued at US$ 880 million in 2025 and is anticipated to reach US$ 1356 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Blood-Gas Exchanger is a sterile, single-use extracorporeal medical device designed to supply oxygen to human blood and remove carbon dioxide during extracorporeal circulation. Modern Blood-Gas Exchanger products predominantly use hollow-fiber membrane structures, with microporous polypropylene widely applied in conventional cardiopulmonary bypass and polymethylpentene increasingly used for prolonged extracorporeal respiratory and cardiopulmonary support. Product performance is differentiated by rated blood flow, membrane surface area, priming volume, blood-side pressure drop, gas-transfer efficiency, heat-exchange capability, patient population, surface treatment and intended support duration. Higher-integration configurations may incorporate heat exchange, arterial filtration, blood reservoirs and monitoring functions into the Blood-Gas Exchanger module. Principal clinical applications include cardiopulmonary bypass during cardiac surgery and prolonged extracorporeal life support, with dedicated configurations for adult, pediatric and neonatal patients.
Key Findings
Cardiopulmonary bypass remains the principal routine application for Blood-Gas Exchanger products by procedure-driven unit demand
Prolonged extracorporeal support is increasing the strategic importance of polymethylpentene membrane Blood-Gas Exchanger products
Low priming volume, hemocompatible surfaces and integrated filtration are becoming key product differentiation factors
Competition increasingly depends on membrane engineering, integrated perfusion platforms, regulatory capability and specialized clinical channels
Market Trends
Blood-Gas Exchanger technology is evolving from a primary focus on gas-transfer efficiency toward integrated optimization of hemocompatibility, circuit simplicity, prolonged durability and device monitoring. In cardiopulmonary bypass, manufacturers continue to reduce priming volume and blood-side pressure drop while optimizing flow paths and integrating arterial filtration, heat exchange and reservoir functions. In prolonged extracorporeal support, membrane stability, reduced plasma leakage, sustained oxygen and carbon dioxide transfer and thromboresistance are becoming increasingly important, strengthening the role of polymethylpentene membrane technology. Blood-contact surface technologies are also advancing toward specialized polymeric, phosphorylcholine, heparin-based and other hemocompatible treatments. At the higher end of the market, pressure, temperature and oxygenation monitoring are increasingly being incorporated into the Blood-Gas Exchanger module, moving selected products toward intelligent components within integrated extracorporeal support platforms.
Market Dynamics
Drivers
Demand for Blood-Gas Exchanger products is supported by a recurring disposable-consumable model, because each cardiopulmonary bypass or extracorporeal support procedure requires dedicated blood-gas exchange components. Cardiac surgery remains the fundamental demand base, including coronary, valvular, congenital and other procedures requiring extracorporeal circulation. Expansion of advanced critical-care capabilities is simultaneously increasing the number of institutions able to provide prolonged extracorporeal respiratory or cardiopulmonary support. Hospitals are also placing greater emphasis on lower priming volume, stable gas exchange, reduced blood trauma, better hemocompatibility and simplified circuit management. Manufacturers with established perfusion or extracorporeal support platforms can further strengthen recurring consumable demand through equipment compatibility, standardized clinical workflows and integrated product portfolios.
Restraints
Blood-Gas Exchanger manufacturing requires precise control of hollow-fiber membranes, fiber potting, blood-contact polymers, flow-path geometry, surface treatment, heat exchange, sterilization and quality assurance. Gas-transfer performance must remain stable across changing flow conditions while pressure drop, hemolysis, thrombogenicity and leakage risks are tightly controlled, creating substantial technical and regulatory barriers. Mature cardiopulmonary bypass markets are also exposed to hospital procurement and cost-containment pressure, limiting pricing flexibility when competing products provide similar baseline performance. Prolonged extracorporeal support additionally depends on trained clinical teams, intensive-care infrastructure and standardized institutional protocols, restricting adoption in healthcare systems with insufficient perfusion and critical-care resources.
Opportunities
The most attractive opportunities are concentrated in prolonged extracorporeal support, high-performance membrane materials, hemocompatible surface technologies, low-prime designs and integrated monitoring. Technologies that extend stable blood-gas exchange while reducing plasma leakage, flow resistance and thrombotic risk can create meaningful product differentiation. Pediatric and neonatal Blood-Gas Exchanger products also represent technically demanding niches because lower extracorporeal volume and precise low-flow control impose stricter requirements than standard adult applications. Localization of critical extracorporeal devices in large emerging healthcare markets creates additional opportunities for manufacturers capable of combining regulatory compliance, manufacturing consistency and cost competitiveness. Integration of pressure, temperature and oxygenation monitoring may further increase product value and strengthen compatibility with next-generation extracorporeal support platforms.
Challenges
The principal technical challenge is balancing multiple performance objectives within a compact disposable device. Reducing priming volume and blood-contact surface area can conflict with requirements for membrane area, gas-transfer capacity and pressure control, while prolonged operation increases demands on membrane integrity, surface-treatment stability and thromboresistance. Specialized hollow-fiber materials and medical-grade components can create supply-chain dependencies, while quality deviations may have direct clinical, regulatory and reputational consequences. Competition is also becoming more complex as established cardiopulmonary companies, extracorporeal support platform suppliers and emerging domestic manufacturers expand across overlapping product categories. Commercial success therefore increasingly depends on a combination of device performance, regulatory execution, manufacturing scale, hospital access, clinical support and reliable product availability.
Industry Chain Analysis
The upstream Blood-Gas Exchanger industry is centered on hollow-fiber membrane materials, medical-grade polymer housings, potting compounds, heat-exchange components, arterial filtration media, surface-treatment materials, connectors and selected embedded sensing components. Microporous polypropylene remains important in conventional cardiopulmonary bypass applications, while polymethylpentene has greater strategic relevance for prolonged extracorporeal support because of its suitability for sustained blood-gas exchange and lower plasma leakage. Manufacturing involves membrane-bundle formation, precision fiber potting, housing molding, blood-flow-path engineering, surface treatment, assembly, sterilization and extensive functional testing. Value creation is therefore concentrated not only in raw materials but also in membrane engineering, fluid dynamics, hemocompatibility and reproducible manufacturing quality.
Midstream manufacturers are increasingly competing through integrated perfusion and extracorporeal support portfolios rather than stand-alone Blood-Gas Exchanger products alone. Integration of heat exchangers, arterial filters, reservoirs, specialized surface treatments and monitoring features can raise product value while reducing circuit complexity for clinical users. Downstream demand is concentrated in cardiac surgery centers, perfusion departments, intensive-care units and extracorporeal life-support programs. Because Blood-Gas Exchanger products are single-use devices, procedure volumes translate directly into recurring consumption. Compatibility with heart-lung machines, blood pumps, tubing sets and extracorporeal support platforms can further increase customer retention, while industry profitability is influenced by membrane sourcing, manufacturing yield, regulatory compliance, product integration, clinical support and direct hospital access.
Segment Insights
By clinical application, cardiopulmonary bypass Blood-Gas Exchanger products remain the principal unit-volume segment because cardiac surgery creates recurring and relatively predictable single-procedure demand. This segment has a mature hollow-fiber technology base and places strong emphasis on reliable gas transfer, low priming volume, compact circuit design and integration of heat-exchange, arterial filtration and reservoir functions. Adult products represent the majority of routine clinical use, while pediatric and neonatal configurations constitute smaller but more technically specialized segments requiring tighter control of extracorporeal volume, blood flow and pressure drop.
Prolonged extracorporeal support represents the more technology-intensive development direction. Polymethylpentene membrane Blood-Gas Exchanger products are increasingly important where extended support requires durable gas exchange and lower plasma leakage. Hemocompatible surfaces, optimized flow paths and integrated monitoring further differentiate higher-value products. Competitive focus is consequently moving beyond gas-transfer capacity alone toward combined performance in blood compatibility, durability, pressure management, circuit simplification and device-state monitoring. This shift favors manufacturers capable of integrating membrane science, materials engineering and system-level design rather than competing primarily on standard disposable specifications.
Downstream Market Opportunities
Cardiac surgery remains the principal downstream market for Blood-Gas Exchanger products because cardiopulmonary bypass creates direct and recurring device consumption. Incremental opportunity is increasingly associated with intensive-care applications requiring prolonged respiratory or cardiopulmonary support, where hospitals are strengthening extracorporeal life-support capabilities and demanding greater durability, lower thrombogenicity and simpler circuit management. Advanced tertiary hospitals remain the primary users of high-performance products, while continued development of cardiac surgery and critical-care infrastructure in emerging markets expands the addressable customer base. Pediatric cardiac surgery and neonatal extracorporeal support remain lower-volume but higher-technical-barrier applications, creating specialized opportunities for low-prime and low-flow Blood-Gas Exchanger products.
Regional Insights
North America and Europe remain major high-value markets for Blood-Gas Exchanger products, supported by mature cardiac surgery networks, established perfusion practice and extensive extracorporeal life-support capacity. Hospitals in these regions generally place greater emphasis on clinical evidence, regulatory compliance, hemocompatibility, integrated circuit design and supplier service capabilities. Europe also maintains a substantial manufacturing and technology base in cardiopulmonary and extracorporeal support devices, supporting continued development of advanced membranes, surface treatments, integrated circuits and prolonged-support solutions.
Asia Pacific is becoming increasingly important from both demand and manufacturing perspectives. Japan has a mature domestic cardiopulmonary device industry with established Blood-Gas Exchanger manufacturers and long-standing perfusion expertise. China is developing stronger domestic capabilities in membrane blood-gas exchange and extracorporeal support systems as cardiac surgery capacity, critical-care infrastructure and localization of strategic medical devices continue to advance. South Korea has begun developing domestic Blood-Gas Exchanger technology, although commercial maturity remains lower than in Japan and China. Other Asian markets continue to rely more heavily on imported devices, making regulatory access, distributor coverage, clinical education and dependable product supply important determinants of regional expansion.
Competitive Landscape Analysis
The Blood-Gas Exchanger market is characterized by high technical and regulatory barriers and a limited group of manufacturers with established cardiopulmonary or extracorporeal support capabilities. Medtronic plc, Terumo Corporation, LivaNova PLC and Getinge AB participate through broad perfusion platforms, global hospital relationships and complementary disposable portfolios. Fresenius Medical Care AG is positioned primarily through extracorporeal life-support solutions, while Eurosets S.r.l. maintains a portfolio spanning conventional cardiopulmonary bypass and prolonged support. Nipro Corporation and SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. maintain established cardiopulmonary capabilities with particular strength in Japan and selected international markets, while Spectrum Medical S.r.l. combines perfusion technologies with integrated monitoring and digital system capabilities. In China, Dongguan Kewei Medical Instrument Co., Ltd., Shenzhen Lifemotion Medical Technology Co., Ltd. and Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. represent the development of domestic Blood-Gas Exchanger and extracorporeal support manufacturing. Competitive advantage increasingly depends on membrane durability, low-prime engineering, hemocompatible surfaces, integrated filtration, prolonged-support performance, monitoring capability, manufacturing consistency and access to specialized clinical channels.
Report Scope
This report delivers a comprehensive overview of the global Blood-Gas Exchanger market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood-Gas Exchanger. The Blood-Gas Exchanger market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood-Gas Exchanger market comprehensively. Regional market sizes by Type, by Application, by Support Duration, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood-Gas Exchanger manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic plc
Terumo Corporation
LivaNova PLC
Getinge AB
Fresenius Medical Care AG
Eurosets S.r.l.
Nipro Corporation
SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
Spectrum Medical S.r.l.
Dongguan Kewei Medical Instrument Co., Ltd.
Shenzhen Lifemotion Medical Technology Co., Ltd.
Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
Segment by Type
Cardiopulmonary Bypass Oxygenators
Extracorporeal Membrane Oxygenation Oxygenators
Others
Segment by Support Duration
Short-Term Oxygenators Up to 6 Hours
Long-Term Oxygenators Over 6 Hours
Segment by Membrane Material
Microporous Polypropylene Oxygenators
Polymethylpentene Oxygenators
Others
by Application
Adult Oxygenators
Pediatric and Neonatal Oxygenators
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Support Duration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood-Gas Exchanger manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood-Gas Exchanger sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Blood-Gas Exchanger is a sterile, single-use extracorporeal medical device designed to supply oxygen to human blood and remove carbon dioxide during extracorporeal circulation. Modern Blood-Gas Exchanger products predominantly use hollow-fiber membrane structures, with microporous polypropylene widely applied in conventional cardiopulmonary bypass and polymethylpentene increasingly used for prolonged extracorporeal respiratory and cardiopulmonary support. Product performance is differentiated by rated blood flow, membrane surface area, priming volume, blood-side pressure drop, gas-transfer efficiency, heat-exchange capability, patient population, surface treatment and intended support duration. Higher-integration configurations may incorporate heat exchange, arterial filtration, blood reservoirs and monitoring functions into the Blood-Gas Exchanger module. Principal clinical applications include cardiopulmonary bypass during cardiac surgery and prolonged extracorporeal life support, with dedicated configurations for adult, pediatric and neonatal patients.
Key Findings
Cardiopulmonary bypass remains the principal routine application for Blood-Gas Exchanger products by procedure-driven unit demand
Prolonged extracorporeal support is increasing the strategic importance of polymethylpentene membrane Blood-Gas Exchanger products
Low priming volume, hemocompatible surfaces and integrated filtration are becoming key product differentiation factors
Competition increasingly depends on membrane engineering, integrated perfusion platforms, regulatory capability and specialized clinical channels
Market Trends
Blood-Gas Exchanger technology is evolving from a primary focus on gas-transfer efficiency toward integrated optimization of hemocompatibility, circuit simplicity, prolonged durability and device monitoring. In cardiopulmonary bypass, manufacturers continue to reduce priming volume and blood-side pressure drop while optimizing flow paths and integrating arterial filtration, heat exchange and reservoir functions. In prolonged extracorporeal support, membrane stability, reduced plasma leakage, sustained oxygen and carbon dioxide transfer and thromboresistance are becoming increasingly important, strengthening the role of polymethylpentene membrane technology. Blood-contact surface technologies are also advancing toward specialized polymeric, phosphorylcholine, heparin-based and other hemocompatible treatments. At the higher end of the market, pressure, temperature and oxygenation monitoring are increasingly being incorporated into the Blood-Gas Exchanger module, moving selected products toward intelligent components within integrated extracorporeal support platforms.
Market Dynamics
Drivers
Demand for Blood-Gas Exchanger products is supported by a recurring disposable-consumable model, because each cardiopulmonary bypass or extracorporeal support procedure requires dedicated blood-gas exchange components. Cardiac surgery remains the fundamental demand base, including coronary, valvular, congenital and other procedures requiring extracorporeal circulation. Expansion of advanced critical-care capabilities is simultaneously increasing the number of institutions able to provide prolonged extracorporeal respiratory or cardiopulmonary support. Hospitals are also placing greater emphasis on lower priming volume, stable gas exchange, reduced blood trauma, better hemocompatibility and simplified circuit management. Manufacturers with established perfusion or extracorporeal support platforms can further strengthen recurring consumable demand through equipment compatibility, standardized clinical workflows and integrated product portfolios.
Restraints
Blood-Gas Exchanger manufacturing requires precise control of hollow-fiber membranes, fiber potting, blood-contact polymers, flow-path geometry, surface treatment, heat exchange, sterilization and quality assurance. Gas-transfer performance must remain stable across changing flow conditions while pressure drop, hemolysis, thrombogenicity and leakage risks are tightly controlled, creating substantial technical and regulatory barriers. Mature cardiopulmonary bypass markets are also exposed to hospital procurement and cost-containment pressure, limiting pricing flexibility when competing products provide similar baseline performance. Prolonged extracorporeal support additionally depends on trained clinical teams, intensive-care infrastructure and standardized institutional protocols, restricting adoption in healthcare systems with insufficient perfusion and critical-care resources.
Opportunities
The most attractive opportunities are concentrated in prolonged extracorporeal support, high-performance membrane materials, hemocompatible surface technologies, low-prime designs and integrated monitoring. Technologies that extend stable blood-gas exchange while reducing plasma leakage, flow resistance and thrombotic risk can create meaningful product differentiation. Pediatric and neonatal Blood-Gas Exchanger products also represent technically demanding niches because lower extracorporeal volume and precise low-flow control impose stricter requirements than standard adult applications. Localization of critical extracorporeal devices in large emerging healthcare markets creates additional opportunities for manufacturers capable of combining regulatory compliance, manufacturing consistency and cost competitiveness. Integration of pressure, temperature and oxygenation monitoring may further increase product value and strengthen compatibility with next-generation extracorporeal support platforms.
Challenges
The principal technical challenge is balancing multiple performance objectives within a compact disposable device. Reducing priming volume and blood-contact surface area can conflict with requirements for membrane area, gas-transfer capacity and pressure control, while prolonged operation increases demands on membrane integrity, surface-treatment stability and thromboresistance. Specialized hollow-fiber materials and medical-grade components can create supply-chain dependencies, while quality deviations may have direct clinical, regulatory and reputational consequences. Competition is also becoming more complex as established cardiopulmonary companies, extracorporeal support platform suppliers and emerging domestic manufacturers expand across overlapping product categories. Commercial success therefore increasingly depends on a combination of device performance, regulatory execution, manufacturing scale, hospital access, clinical support and reliable product availability.
Industry Chain Analysis
The upstream Blood-Gas Exchanger industry is centered on hollow-fiber membrane materials, medical-grade polymer housings, potting compounds, heat-exchange components, arterial filtration media, surface-treatment materials, connectors and selected embedded sensing components. Microporous polypropylene remains important in conventional cardiopulmonary bypass applications, while polymethylpentene has greater strategic relevance for prolonged extracorporeal support because of its suitability for sustained blood-gas exchange and lower plasma leakage. Manufacturing involves membrane-bundle formation, precision fiber potting, housing molding, blood-flow-path engineering, surface treatment, assembly, sterilization and extensive functional testing. Value creation is therefore concentrated not only in raw materials but also in membrane engineering, fluid dynamics, hemocompatibility and reproducible manufacturing quality.
Midstream manufacturers are increasingly competing through integrated perfusion and extracorporeal support portfolios rather than stand-alone Blood-Gas Exchanger products alone. Integration of heat exchangers, arterial filters, reservoirs, specialized surface treatments and monitoring features can raise product value while reducing circuit complexity for clinical users. Downstream demand is concentrated in cardiac surgery centers, perfusion departments, intensive-care units and extracorporeal life-support programs. Because Blood-Gas Exchanger products are single-use devices, procedure volumes translate directly into recurring consumption. Compatibility with heart-lung machines, blood pumps, tubing sets and extracorporeal support platforms can further increase customer retention, while industry profitability is influenced by membrane sourcing, manufacturing yield, regulatory compliance, product integration, clinical support and direct hospital access.
Segment Insights
By clinical application, cardiopulmonary bypass Blood-Gas Exchanger products remain the principal unit-volume segment because cardiac surgery creates recurring and relatively predictable single-procedure demand. This segment has a mature hollow-fiber technology base and places strong emphasis on reliable gas transfer, low priming volume, compact circuit design and integration of heat-exchange, arterial filtration and reservoir functions. Adult products represent the majority of routine clinical use, while pediatric and neonatal configurations constitute smaller but more technically specialized segments requiring tighter control of extracorporeal volume, blood flow and pressure drop.
Prolonged extracorporeal support represents the more technology-intensive development direction. Polymethylpentene membrane Blood-Gas Exchanger products are increasingly important where extended support requires durable gas exchange and lower plasma leakage. Hemocompatible surfaces, optimized flow paths and integrated monitoring further differentiate higher-value products. Competitive focus is consequently moving beyond gas-transfer capacity alone toward combined performance in blood compatibility, durability, pressure management, circuit simplification and device-state monitoring. This shift favors manufacturers capable of integrating membrane science, materials engineering and system-level design rather than competing primarily on standard disposable specifications.
Downstream Market Opportunities
Cardiac surgery remains the principal downstream market for Blood-Gas Exchanger products because cardiopulmonary bypass creates direct and recurring device consumption. Incremental opportunity is increasingly associated with intensive-care applications requiring prolonged respiratory or cardiopulmonary support, where hospitals are strengthening extracorporeal life-support capabilities and demanding greater durability, lower thrombogenicity and simpler circuit management. Advanced tertiary hospitals remain the primary users of high-performance products, while continued development of cardiac surgery and critical-care infrastructure in emerging markets expands the addressable customer base. Pediatric cardiac surgery and neonatal extracorporeal support remain lower-volume but higher-technical-barrier applications, creating specialized opportunities for low-prime and low-flow Blood-Gas Exchanger products.
Regional Insights
North America and Europe remain major high-value markets for Blood-Gas Exchanger products, supported by mature cardiac surgery networks, established perfusion practice and extensive extracorporeal life-support capacity. Hospitals in these regions generally place greater emphasis on clinical evidence, regulatory compliance, hemocompatibility, integrated circuit design and supplier service capabilities. Europe also maintains a substantial manufacturing and technology base in cardiopulmonary and extracorporeal support devices, supporting continued development of advanced membranes, surface treatments, integrated circuits and prolonged-support solutions.
Asia Pacific is becoming increasingly important from both demand and manufacturing perspectives. Japan has a mature domestic cardiopulmonary device industry with established Blood-Gas Exchanger manufacturers and long-standing perfusion expertise. China is developing stronger domestic capabilities in membrane blood-gas exchange and extracorporeal support systems as cardiac surgery capacity, critical-care infrastructure and localization of strategic medical devices continue to advance. South Korea has begun developing domestic Blood-Gas Exchanger technology, although commercial maturity remains lower than in Japan and China. Other Asian markets continue to rely more heavily on imported devices, making regulatory access, distributor coverage, clinical education and dependable product supply important determinants of regional expansion.
Competitive Landscape Analysis
The Blood-Gas Exchanger market is characterized by high technical and regulatory barriers and a limited group of manufacturers with established cardiopulmonary or extracorporeal support capabilities. Medtronic plc, Terumo Corporation, LivaNova PLC and Getinge AB participate through broad perfusion platforms, global hospital relationships and complementary disposable portfolios. Fresenius Medical Care AG is positioned primarily through extracorporeal life-support solutions, while Eurosets S.r.l. maintains a portfolio spanning conventional cardiopulmonary bypass and prolonged support. Nipro Corporation and SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. maintain established cardiopulmonary capabilities with particular strength in Japan and selected international markets, while Spectrum Medical S.r.l. combines perfusion technologies with integrated monitoring and digital system capabilities. In China, Dongguan Kewei Medical Instrument Co., Ltd., Shenzhen Lifemotion Medical Technology Co., Ltd. and Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. represent the development of domestic Blood-Gas Exchanger and extracorporeal support manufacturing. Competitive advantage increasingly depends on membrane durability, low-prime engineering, hemocompatible surfaces, integrated filtration, prolonged-support performance, monitoring capability, manufacturing consistency and access to specialized clinical channels.
Report Scope
This report delivers a comprehensive overview of the global Blood-Gas Exchanger market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood-Gas Exchanger. The Blood-Gas Exchanger market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood-Gas Exchanger market comprehensively. Regional market sizes by Type, by Application, by Support Duration, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood-Gas Exchanger manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic plc
Terumo Corporation
LivaNova PLC
Getinge AB
Fresenius Medical Care AG
Eurosets S.r.l.
Nipro Corporation
SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
Spectrum Medical S.r.l.
Dongguan Kewei Medical Instrument Co., Ltd.
Shenzhen Lifemotion Medical Technology Co., Ltd.
Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
Segment by Type
Cardiopulmonary Bypass Oxygenators
Extracorporeal Membrane Oxygenation Oxygenators
Others
Segment by Support Duration
Short-Term Oxygenators Up to 6 Hours
Long-Term Oxygenators Over 6 Hours
Segment by Membrane Material
Microporous Polypropylene Oxygenators
Polymethylpentene Oxygenators
Others
by Application
Adult Oxygenators
Pediatric and Neonatal Oxygenators
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Support Duration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood-Gas Exchanger manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood-Gas Exchanger sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Blood-Gas Exchanger Market Overview
1.1 Product Definition
1.2 Blood-Gas Exchanger by Type
1.2.1 Global Blood-Gas Exchanger Market Value by Type: 2025 vs 2032
1.2.2 Cardiopulmonary Bypass Oxygenators
1.2.3 Extracorporeal Membrane Oxygenation Oxygenators
1.2.4 Others
1.3 Blood-Gas Exchanger by Support Duration
1.3.1 Global Blood-Gas Exchanger Market Value by Support Duration: 2025 vs 2032
1.3.2 Short-Term Oxygenators Up to 6 Hours
1.3.3 Long-Term Oxygenators Over 6 Hours
1.4 Blood-Gas Exchanger by Membrane Material
1.4.1 Global Blood-Gas Exchanger Market Value by Membrane Material: 2025 vs 2032
1.4.2 Microporous Polypropylene Oxygenators
1.4.3 Polymethylpentene Oxygenators
1.4.4 Others
1.5 Blood-Gas Exchanger by Application
1.5.1 Global Blood-Gas Exchanger Market Value by Application: 2025 vs 2032
1.5.2 Adult Oxygenators
1.5.3 Pediatric and Neonatal Oxygenators
1.6 Global Blood-Gas Exchanger Market Size Estimates and Forecasts
1.6.1 Global Blood-Gas Exchanger Revenue 2021–2032
1.6.2 Global Blood-Gas Exchanger Sales 2021–2032
1.6.3 Global Blood-Gas Exchanger Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Blood-Gas Exchanger Market Competition by Manufacturers
2.1 Global Blood-Gas Exchanger Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood-Gas Exchanger Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood-Gas Exchanger Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood-Gas Exchanger, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood-Gas Exchanger, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood-Gas Exchanger, Product Types and Applications
2.7 Global Key Manufacturers of Blood-Gas Exchanger, Date of Entry into the Industry
2.8 Global Blood-Gas Exchanger Market Competitive Situation and Trends
2.8.1 Global Blood-Gas Exchanger Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood-Gas Exchanger Players Market Share by Revenue
2.8.3 Global Blood-Gas Exchanger Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood-Gas Exchanger Market Scenario by Region
3.1 Global Blood-Gas Exchanger Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood-Gas Exchanger Sales by Region: 2021–2032
3.2.1 Global Blood-Gas Exchanger Sales by Region: 2021–2026
3.2.2 Global Blood-Gas Exchanger Sales by Region: 2027–2032
3.3 Global Blood-Gas Exchanger Revenue by Region: 2021–2032
3.3.1 Global Blood-Gas Exchanger Revenue by Region: 2021–2026
3.3.2 Global Blood-Gas Exchanger Revenue by Region: 2027–2032
3.4 North America Blood-Gas Exchanger Market Facts & Figures by Country
3.4.1 North America Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood-Gas Exchanger Sales by Country (2021–2032)
3.4.3 North America Blood-Gas Exchanger Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood-Gas Exchanger Market Facts & Figures by Country
3.5.1 Europe Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood-Gas Exchanger Sales by Country (2021–2032)
3.5.3 Europe Blood-Gas Exchanger Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood-Gas Exchanger Market Facts & Figures by Region
3.6.1 Asia Pacific Blood-Gas Exchanger Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood-Gas Exchanger Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood-Gas Exchanger Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood-Gas Exchanger Market Facts & Figures by Country
3.7.1 Latin America Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood-Gas Exchanger Sales by Country (2021–2032)
3.7.3 Latin America Blood-Gas Exchanger Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood-Gas Exchanger Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood-Gas Exchanger Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood-Gas Exchanger Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood-Gas Exchanger Sales by Type (2021–2032)
4.1.1 Global Blood-Gas Exchanger Sales by Type (2021–2026)
4.1.2 Global Blood-Gas Exchanger Sales by Type (2027–2032)
4.1.3 Global Blood-Gas Exchanger Sales Market Share by Type (2021–2032)
4.2 Global Blood-Gas Exchanger Revenue by Type (2021–2032)
4.2.1 Global Blood-Gas Exchanger Revenue by Type (2021–2026)
4.2.2 Global Blood-Gas Exchanger Revenue by Type (2027–2032)
4.2.3 Global Blood-Gas Exchanger Revenue Market Share by Type (2021–2032)
4.3 Global Blood-Gas Exchanger Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood-Gas Exchanger Sales by Application (2021–2032)
5.1.1 Global Blood-Gas Exchanger Sales by Application (2021–2026)
5.1.2 Global Blood-Gas Exchanger Sales by Application (2027–2032)
5.1.3 Global Blood-Gas Exchanger Sales Market Share by Application (2021–2032)
5.2 Global Blood-Gas Exchanger Revenue by Application (2021–2032)
5.2.1 Global Blood-Gas Exchanger Revenue by Application (2021–2026)
5.2.2 Global Blood-Gas Exchanger Revenue by Application (2027–2032)
5.2.3 Global Blood-Gas Exchanger Revenue Market Share by Application (2021–2032)
5.3 Global Blood-Gas Exchanger Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Company Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic plc Blood-Gas Exchanger Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Company Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Corporation Blood-Gas Exchanger Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 LivaNova PLC
6.3.1 LivaNova PLC Company Information
6.3.2 LivaNova PLC Description and Business Overview
6.3.3 LivaNova PLC Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova PLC Blood-Gas Exchanger Product Portfolio
6.3.5 LivaNova PLC Recent Developments/Updates
6.4 Getinge AB
6.4.1 Getinge AB Company Information
6.4.2 Getinge AB Description and Business Overview
6.4.3 Getinge AB Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Getinge AB Blood-Gas Exchanger Product Portfolio
6.4.5 Getinge AB Recent Developments/Updates
6.5 Fresenius Medical Care AG
6.5.1 Fresenius Medical Care AG Company Information
6.5.2 Fresenius Medical Care AG Description and Business Overview
6.5.3 Fresenius Medical Care AG Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care AG Blood-Gas Exchanger Product Portfolio
6.5.5 Fresenius Medical Care AG Recent Developments/Updates
6.6 Eurosets S.r.l.
6.6.1 Eurosets S.r.l. Company Information
6.6.2 Eurosets S.r.l. Description and Business Overview
6.6.3 Eurosets S.r.l. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eurosets S.r.l. Blood-Gas Exchanger Product Portfolio
6.6.5 Eurosets S.r.l. Recent Developments/Updates
6.7 Nipro Corporation
6.7.1 Nipro Corporation Company Information
6.7.2 Nipro Corporation Description and Business Overview
6.7.3 Nipro Corporation Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Nipro Corporation Blood-Gas Exchanger Product Portfolio
6.7.5 Nipro Corporation Recent Developments/Updates
6.8 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
6.8.1 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
6.8.2 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
6.8.3 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Product Portfolio
6.8.5 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
6.9 Spectrum Medical S.r.l.
6.9.1 Spectrum Medical S.r.l. Company Information
6.9.2 Spectrum Medical S.r.l. Description and Business Overview
6.9.3 Spectrum Medical S.r.l. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Spectrum Medical S.r.l. Blood-Gas Exchanger Product Portfolio
6.9.5 Spectrum Medical S.r.l. Recent Developments/Updates
6.10 Dongguan Kewei Medical Instrument Co., Ltd.
6.10.1 Dongguan Kewei Medical Instrument Co., Ltd. Company Information
6.10.2 Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
6.10.3 Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.10.5 Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
6.11 Shenzhen Lifemotion Medical Technology Co., Ltd.
6.11.1 Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
6.11.2 Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
6.11.3 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.11.5 Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
6.12 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
6.12.1 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
6.12.2 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
6.12.3 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.12.5 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood-Gas Exchanger Industry Chain Analysis
7.2 Blood-Gas Exchanger Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood-Gas Exchanger Production Mode & Process Analysis
7.4 Blood-Gas Exchanger Sales and Marketing
7.4.1 Blood-Gas Exchanger Sales Channels
7.4.2 Blood-Gas Exchanger Distributors
7.5 Blood-Gas Exchanger Customer Analysis
8 Blood-Gas Exchanger Market Dynamics
8.1 Blood-Gas Exchanger Industry Trends
8.2 Blood-Gas Exchanger Market Drivers
8.3 Blood-Gas Exchanger Market Challenges
8.4 Blood-Gas Exchanger Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Blood-Gas Exchanger by Type
1.2.1 Global Blood-Gas Exchanger Market Value by Type: 2025 vs 2032
1.2.2 Cardiopulmonary Bypass Oxygenators
1.2.3 Extracorporeal Membrane Oxygenation Oxygenators
1.2.4 Others
1.3 Blood-Gas Exchanger by Support Duration
1.3.1 Global Blood-Gas Exchanger Market Value by Support Duration: 2025 vs 2032
1.3.2 Short-Term Oxygenators Up to 6 Hours
1.3.3 Long-Term Oxygenators Over 6 Hours
1.4 Blood-Gas Exchanger by Membrane Material
1.4.1 Global Blood-Gas Exchanger Market Value by Membrane Material: 2025 vs 2032
1.4.2 Microporous Polypropylene Oxygenators
1.4.3 Polymethylpentene Oxygenators
1.4.4 Others
1.5 Blood-Gas Exchanger by Application
1.5.1 Global Blood-Gas Exchanger Market Value by Application: 2025 vs 2032
1.5.2 Adult Oxygenators
1.5.3 Pediatric and Neonatal Oxygenators
1.6 Global Blood-Gas Exchanger Market Size Estimates and Forecasts
1.6.1 Global Blood-Gas Exchanger Revenue 2021–2032
1.6.2 Global Blood-Gas Exchanger Sales 2021–2032
1.6.3 Global Blood-Gas Exchanger Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Blood-Gas Exchanger Market Competition by Manufacturers
2.1 Global Blood-Gas Exchanger Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood-Gas Exchanger Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood-Gas Exchanger Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood-Gas Exchanger, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood-Gas Exchanger, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood-Gas Exchanger, Product Types and Applications
2.7 Global Key Manufacturers of Blood-Gas Exchanger, Date of Entry into the Industry
2.8 Global Blood-Gas Exchanger Market Competitive Situation and Trends
2.8.1 Global Blood-Gas Exchanger Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood-Gas Exchanger Players Market Share by Revenue
2.8.3 Global Blood-Gas Exchanger Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood-Gas Exchanger Market Scenario by Region
3.1 Global Blood-Gas Exchanger Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood-Gas Exchanger Sales by Region: 2021–2032
3.2.1 Global Blood-Gas Exchanger Sales by Region: 2021–2026
3.2.2 Global Blood-Gas Exchanger Sales by Region: 2027–2032
3.3 Global Blood-Gas Exchanger Revenue by Region: 2021–2032
3.3.1 Global Blood-Gas Exchanger Revenue by Region: 2021–2026
3.3.2 Global Blood-Gas Exchanger Revenue by Region: 2027–2032
3.4 North America Blood-Gas Exchanger Market Facts & Figures by Country
3.4.1 North America Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood-Gas Exchanger Sales by Country (2021–2032)
3.4.3 North America Blood-Gas Exchanger Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood-Gas Exchanger Market Facts & Figures by Country
3.5.1 Europe Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood-Gas Exchanger Sales by Country (2021–2032)
3.5.3 Europe Blood-Gas Exchanger Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood-Gas Exchanger Market Facts & Figures by Region
3.6.1 Asia Pacific Blood-Gas Exchanger Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood-Gas Exchanger Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood-Gas Exchanger Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood-Gas Exchanger Market Facts & Figures by Country
3.7.1 Latin America Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood-Gas Exchanger Sales by Country (2021–2032)
3.7.3 Latin America Blood-Gas Exchanger Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood-Gas Exchanger Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood-Gas Exchanger Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood-Gas Exchanger Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood-Gas Exchanger Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood-Gas Exchanger Sales by Type (2021–2032)
4.1.1 Global Blood-Gas Exchanger Sales by Type (2021–2026)
4.1.2 Global Blood-Gas Exchanger Sales by Type (2027–2032)
4.1.3 Global Blood-Gas Exchanger Sales Market Share by Type (2021–2032)
4.2 Global Blood-Gas Exchanger Revenue by Type (2021–2032)
4.2.1 Global Blood-Gas Exchanger Revenue by Type (2021–2026)
4.2.2 Global Blood-Gas Exchanger Revenue by Type (2027–2032)
4.2.3 Global Blood-Gas Exchanger Revenue Market Share by Type (2021–2032)
4.3 Global Blood-Gas Exchanger Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood-Gas Exchanger Sales by Application (2021–2032)
5.1.1 Global Blood-Gas Exchanger Sales by Application (2021–2026)
5.1.2 Global Blood-Gas Exchanger Sales by Application (2027–2032)
5.1.3 Global Blood-Gas Exchanger Sales Market Share by Application (2021–2032)
5.2 Global Blood-Gas Exchanger Revenue by Application (2021–2032)
5.2.1 Global Blood-Gas Exchanger Revenue by Application (2021–2026)
5.2.2 Global Blood-Gas Exchanger Revenue by Application (2027–2032)
5.2.3 Global Blood-Gas Exchanger Revenue Market Share by Application (2021–2032)
5.3 Global Blood-Gas Exchanger Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Company Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic plc Blood-Gas Exchanger Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Company Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Corporation Blood-Gas Exchanger Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 LivaNova PLC
6.3.1 LivaNova PLC Company Information
6.3.2 LivaNova PLC Description and Business Overview
6.3.3 LivaNova PLC Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova PLC Blood-Gas Exchanger Product Portfolio
6.3.5 LivaNova PLC Recent Developments/Updates
6.4 Getinge AB
6.4.1 Getinge AB Company Information
6.4.2 Getinge AB Description and Business Overview
6.4.3 Getinge AB Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Getinge AB Blood-Gas Exchanger Product Portfolio
6.4.5 Getinge AB Recent Developments/Updates
6.5 Fresenius Medical Care AG
6.5.1 Fresenius Medical Care AG Company Information
6.5.2 Fresenius Medical Care AG Description and Business Overview
6.5.3 Fresenius Medical Care AG Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care AG Blood-Gas Exchanger Product Portfolio
6.5.5 Fresenius Medical Care AG Recent Developments/Updates
6.6 Eurosets S.r.l.
6.6.1 Eurosets S.r.l. Company Information
6.6.2 Eurosets S.r.l. Description and Business Overview
6.6.3 Eurosets S.r.l. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eurosets S.r.l. Blood-Gas Exchanger Product Portfolio
6.6.5 Eurosets S.r.l. Recent Developments/Updates
6.7 Nipro Corporation
6.7.1 Nipro Corporation Company Information
6.7.2 Nipro Corporation Description and Business Overview
6.7.3 Nipro Corporation Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Nipro Corporation Blood-Gas Exchanger Product Portfolio
6.7.5 Nipro Corporation Recent Developments/Updates
6.8 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
6.8.1 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
6.8.2 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
6.8.3 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Product Portfolio
6.8.5 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
6.9 Spectrum Medical S.r.l.
6.9.1 Spectrum Medical S.r.l. Company Information
6.9.2 Spectrum Medical S.r.l. Description and Business Overview
6.9.3 Spectrum Medical S.r.l. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Spectrum Medical S.r.l. Blood-Gas Exchanger Product Portfolio
6.9.5 Spectrum Medical S.r.l. Recent Developments/Updates
6.10 Dongguan Kewei Medical Instrument Co., Ltd.
6.10.1 Dongguan Kewei Medical Instrument Co., Ltd. Company Information
6.10.2 Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
6.10.3 Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.10.5 Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
6.11 Shenzhen Lifemotion Medical Technology Co., Ltd.
6.11.1 Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
6.11.2 Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
6.11.3 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.11.5 Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
6.12 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
6.12.1 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
6.12.2 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
6.12.3 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Product Portfolio
6.12.5 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood-Gas Exchanger Industry Chain Analysis
7.2 Blood-Gas Exchanger Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood-Gas Exchanger Production Mode & Process Analysis
7.4 Blood-Gas Exchanger Sales and Marketing
7.4.1 Blood-Gas Exchanger Sales Channels
7.4.2 Blood-Gas Exchanger Distributors
7.5 Blood-Gas Exchanger Customer Analysis
8 Blood-Gas Exchanger Market Dynamics
8.1 Blood-Gas Exchanger Industry Trends
8.2 Blood-Gas Exchanger Market Drivers
8.3 Blood-Gas Exchanger Market Challenges
8.4 Blood-Gas Exchanger Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Blood-Gas Exchanger Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Blood-Gas Exchanger Market Value by Support Duration (US$ Million), 2025 vs 2032
Table 3. Global Blood-Gas Exchanger Market Value by Membrane Material (US$ Million), 2025 vs 2032
Table 4. Global Blood-Gas Exchanger Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Blood-Gas Exchanger Market Competitive Situation by Manufacturers in 2025
Table 6. Global Blood-Gas Exchanger Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Blood-Gas Exchanger Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Blood-Gas Exchanger Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Blood-Gas Exchanger Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Blood-Gas Exchanger Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Blood-Gas Exchanger, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Blood-Gas Exchanger, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Blood-Gas Exchanger, Product Types and Applications
Table 14. Global Key Manufacturers of Blood-Gas Exchanger, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Blood-Gas Exchanger Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood-Gas Exchanger Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Blood-Gas Exchanger Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Blood-Gas Exchanger Sales by Region (Units), 2021–2026
Table 20. Global Blood-Gas Exchanger Sales Market Share by Region (2021–2026)
Table 21. Global Blood-Gas Exchanger Sales by Region (Units), 2027–2032
Table 22. Global Blood-Gas Exchanger Sales Market Share by Region (2027–2032)
Table 23. Global Blood-Gas Exchanger Revenue by Region (US$ Million), 2021–2026
Table 24. Global Blood-Gas Exchanger Revenue Market Share by Region (2021–2026)
Table 25. Global Blood-Gas Exchanger Revenue by Region (US$ Million), 2027–2032
Table 26. Global Blood-Gas Exchanger Revenue Market Share by Region (2027–2032)
Table 27. North America Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 29. North America Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 30. North America Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 31. North America Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 34. Europe Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 35. Europe Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Blood-Gas Exchanger Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Blood-Gas Exchanger Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Blood-Gas Exchanger Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Blood-Gas Exchanger Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Blood-Gas Exchanger Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 44. Latin America Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 45. Latin America Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 52. Global Blood-Gas Exchanger Sales (Units) by Type (2021–2026)
Table 53. Global Blood-Gas Exchanger Sales (Units) by Type (2027–2032)
Table 54. Global Blood-Gas Exchanger Sales Market Share by Type (2021–2026)
Table 55. Global Blood-Gas Exchanger Sales Market Share by Type (2027–2032)
Table 56. Global Blood-Gas Exchanger Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Blood-Gas Exchanger Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Blood-Gas Exchanger Revenue Market Share by Type (2021–2026)
Table 59. Global Blood-Gas Exchanger Revenue Market Share by Type (2027–2032)
Table 60. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2021–2026)
Table 61. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2027–2032)
Table 62. Global Blood-Gas Exchanger Sales (Units) by Application (2021–2026)
Table 63. Global Blood-Gas Exchanger Sales (Units) by Application (2027–2032)
Table 64. Global Blood-Gas Exchanger Sales Market Share by Application (2021–2026)
Table 65. Global Blood-Gas Exchanger Sales Market Share by Application (2027–2032)
Table 66. Global Blood-Gas Exchanger Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Blood-Gas Exchanger Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Blood-Gas Exchanger Revenue Market Share by Application (2021–2026)
Table 69. Global Blood-Gas Exchanger Revenue Market Share by Application (2027–2032)
Table 70. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2021–2026)
Table 71. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic plc Company Information
Table 73. Medtronic plc Description and Business Overview
Table 74. Medtronic plc Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic plc Blood-Gas Exchanger Product
Table 76. Medtronic plc Recent Developments/Updates
Table 77. Terumo Corporation Company Information
Table 78. Terumo Corporation Description and Business Overview
Table 79. Terumo Corporation Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Terumo Corporation Blood-Gas Exchanger Product
Table 81. Terumo Corporation Recent Developments/Updates
Table 82. LivaNova PLC Company Information
Table 83. LivaNova PLC Description and Business Overview
Table 84. LivaNova PLC Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. LivaNova PLC Blood-Gas Exchanger Product
Table 86. LivaNova PLC Recent Developments/Updates
Table 87. Getinge AB Company Information
Table 88. Getinge AB Description and Business Overview
Table 89. Getinge AB Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Getinge AB Blood-Gas Exchanger Product
Table 91. Getinge AB Recent Developments/Updates
Table 92. Fresenius Medical Care AG Company Information
Table 93. Fresenius Medical Care AG Description and Business Overview
Table 94. Fresenius Medical Care AG Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Fresenius Medical Care AG Blood-Gas Exchanger Product
Table 96. Fresenius Medical Care AG Recent Developments/Updates
Table 97. Eurosets S.r.l. Company Information
Table 98. Eurosets S.r.l. Description and Business Overview
Table 99. Eurosets S.r.l. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Eurosets S.r.l. Blood-Gas Exchanger Product
Table 101. Eurosets S.r.l. Recent Developments/Updates
Table 102. Nipro Corporation Company Information
Table 103. Nipro Corporation Description and Business Overview
Table 104. Nipro Corporation Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Nipro Corporation Blood-Gas Exchanger Product
Table 106. Nipro Corporation Recent Developments/Updates
Table 107. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
Table 108. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
Table 109. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Product
Table 111. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
Table 112. Spectrum Medical S.r.l. Company Information
Table 113. Spectrum Medical S.r.l. Description and Business Overview
Table 114. Spectrum Medical S.r.l. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Spectrum Medical S.r.l. Blood-Gas Exchanger Product
Table 116. Spectrum Medical S.r.l. Recent Developments/Updates
Table 117. Dongguan Kewei Medical Instrument Co., Ltd. Company Information
Table 118. Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
Table 119. Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Product
Table 121. Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
Table 122. Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
Table 123. Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
Table 124. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Product
Table 126. Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
Table 127. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
Table 128. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
Table 129. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Product
Table 131. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Blood-Gas Exchanger Distributors List
Table 135. Blood-Gas Exchanger Customers List
Table 136. Blood-Gas Exchanger Market Trends
Table 137. Blood-Gas Exchanger Market Drivers
Table 138. Blood-Gas Exchanger Market Challenges
Table 139. Blood-Gas Exchanger Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood-Gas Exchanger
Figure 2. Global Blood-Gas Exchanger Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Blood-Gas Exchanger Market Share by Type: 2025 & 2032
Figure 4. Cardiopulmonary Bypass Oxygenators Product Picture
Figure 5. Extracorporeal Membrane Oxygenation Oxygenators Product Picture
Figure 6. Others Product Picture
Figure 7. Global Blood-Gas Exchanger Market Value by Support Duration (US$ Million), 2021–2032
Figure 8. Global Blood-Gas Exchanger Market Share by Support Duration: 2025 vs 2032
Figure 9. Short-Term Oxygenators Up to 6 Hours Product Picture
Figure 10. Long-Term Oxygenators Over 6 Hours Product Picture
Figure 11. Global Blood-Gas Exchanger Market Value by Membrane Material (US$ Million), 2021–2032
Figure 12. Global Blood-Gas Exchanger Market Share by Membrane Material: 2025 vs 2032
Figure 13. Microporous Polypropylene Oxygenators Product Picture
Figure 14. Polymethylpentene Oxygenators Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood-Gas Exchanger Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Blood-Gas Exchanger Market Share by Application: 2025 & 2032
Figure 18. Adult Oxygenators
Figure 19. Pediatric and Neonatal Oxygenators
Figure 20. Global Blood-Gas Exchanger Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Blood-Gas Exchanger Market Size (US$ Million), 2021–2032
Figure 22. Global Blood-Gas Exchanger Sales (Units), 2021–2032
Figure 23. Global Blood-Gas Exchanger Average Price (US$/Unit), 2021–2032
Figure 24. Blood-Gas Exchanger Report Years Considered
Figure 25. Blood-Gas Exchanger Sales Share by Manufacturers in 2025
Figure 26. Global Blood-Gas Exchanger Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Blood-Gas Exchanger Players: Market Share by Revenue in Blood-Gas Exchanger in 2025
Figure 28. Blood-Gas Exchanger Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Blood-Gas Exchanger Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 31. North America Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 32. U.S. Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Canada Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Europe Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 35. Europe Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 36. Germany Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. France Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. U.K. Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Italy Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Russia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Asia Pacific Blood-Gas Exchanger Sales Market Share by Region (2021–2032)
Figure 42. Asia Pacific Blood-Gas Exchanger Revenue Market Share by Region (2021–2032)
Figure 43. China Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Japan Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. South Korea Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. India Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Australia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Taiwan Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Indonesia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Thailand Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Malaysia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Philippines Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 54. Latin America Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. U.A.E Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Blood-Gas Exchanger by Type (2021–2032)
Figure 64. Global Revenue Market Share of Blood-Gas Exchanger by Type (2021–2032)
Figure 65. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Blood-Gas Exchanger by Application (2021–2032)
Figure 67. Global Revenue Market Share of Blood-Gas Exchanger by Application (2021–2032)
Figure 68. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2021–2032)
Figure 69. Blood-Gas Exchanger Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Blood-Gas Exchanger Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Blood-Gas Exchanger Market Value by Support Duration (US$ Million), 2025 vs 2032
Table 3. Global Blood-Gas Exchanger Market Value by Membrane Material (US$ Million), 2025 vs 2032
Table 4. Global Blood-Gas Exchanger Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Blood-Gas Exchanger Market Competitive Situation by Manufacturers in 2025
Table 6. Global Blood-Gas Exchanger Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Blood-Gas Exchanger Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Blood-Gas Exchanger Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Blood-Gas Exchanger Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Blood-Gas Exchanger Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Blood-Gas Exchanger, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Blood-Gas Exchanger, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Blood-Gas Exchanger, Product Types and Applications
Table 14. Global Key Manufacturers of Blood-Gas Exchanger, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Blood-Gas Exchanger Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood-Gas Exchanger Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Blood-Gas Exchanger Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Blood-Gas Exchanger Sales by Region (Units), 2021–2026
Table 20. Global Blood-Gas Exchanger Sales Market Share by Region (2021–2026)
Table 21. Global Blood-Gas Exchanger Sales by Region (Units), 2027–2032
Table 22. Global Blood-Gas Exchanger Sales Market Share by Region (2027–2032)
Table 23. Global Blood-Gas Exchanger Revenue by Region (US$ Million), 2021–2026
Table 24. Global Blood-Gas Exchanger Revenue Market Share by Region (2021–2026)
Table 25. Global Blood-Gas Exchanger Revenue by Region (US$ Million), 2027–2032
Table 26. Global Blood-Gas Exchanger Revenue Market Share by Region (2027–2032)
Table 27. North America Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 29. North America Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 30. North America Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 31. North America Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 34. Europe Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 35. Europe Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Blood-Gas Exchanger Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Blood-Gas Exchanger Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Blood-Gas Exchanger Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Blood-Gas Exchanger Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Blood-Gas Exchanger Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 44. Latin America Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 45. Latin America Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Blood-Gas Exchanger Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Blood-Gas Exchanger Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Blood-Gas Exchanger Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Blood-Gas Exchanger Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Blood-Gas Exchanger Revenue by Country (US$ Million), 2027–2032
Table 52. Global Blood-Gas Exchanger Sales (Units) by Type (2021–2026)
Table 53. Global Blood-Gas Exchanger Sales (Units) by Type (2027–2032)
Table 54. Global Blood-Gas Exchanger Sales Market Share by Type (2021–2026)
Table 55. Global Blood-Gas Exchanger Sales Market Share by Type (2027–2032)
Table 56. Global Blood-Gas Exchanger Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Blood-Gas Exchanger Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Blood-Gas Exchanger Revenue Market Share by Type (2021–2026)
Table 59. Global Blood-Gas Exchanger Revenue Market Share by Type (2027–2032)
Table 60. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2021–2026)
Table 61. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2027–2032)
Table 62. Global Blood-Gas Exchanger Sales (Units) by Application (2021–2026)
Table 63. Global Blood-Gas Exchanger Sales (Units) by Application (2027–2032)
Table 64. Global Blood-Gas Exchanger Sales Market Share by Application (2021–2026)
Table 65. Global Blood-Gas Exchanger Sales Market Share by Application (2027–2032)
Table 66. Global Blood-Gas Exchanger Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Blood-Gas Exchanger Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Blood-Gas Exchanger Revenue Market Share by Application (2021–2026)
Table 69. Global Blood-Gas Exchanger Revenue Market Share by Application (2027–2032)
Table 70. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2021–2026)
Table 71. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic plc Company Information
Table 73. Medtronic plc Description and Business Overview
Table 74. Medtronic plc Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic plc Blood-Gas Exchanger Product
Table 76. Medtronic plc Recent Developments/Updates
Table 77. Terumo Corporation Company Information
Table 78. Terumo Corporation Description and Business Overview
Table 79. Terumo Corporation Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Terumo Corporation Blood-Gas Exchanger Product
Table 81. Terumo Corporation Recent Developments/Updates
Table 82. LivaNova PLC Company Information
Table 83. LivaNova PLC Description and Business Overview
Table 84. LivaNova PLC Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. LivaNova PLC Blood-Gas Exchanger Product
Table 86. LivaNova PLC Recent Developments/Updates
Table 87. Getinge AB Company Information
Table 88. Getinge AB Description and Business Overview
Table 89. Getinge AB Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Getinge AB Blood-Gas Exchanger Product
Table 91. Getinge AB Recent Developments/Updates
Table 92. Fresenius Medical Care AG Company Information
Table 93. Fresenius Medical Care AG Description and Business Overview
Table 94. Fresenius Medical Care AG Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Fresenius Medical Care AG Blood-Gas Exchanger Product
Table 96. Fresenius Medical Care AG Recent Developments/Updates
Table 97. Eurosets S.r.l. Company Information
Table 98. Eurosets S.r.l. Description and Business Overview
Table 99. Eurosets S.r.l. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Eurosets S.r.l. Blood-Gas Exchanger Product
Table 101. Eurosets S.r.l. Recent Developments/Updates
Table 102. Nipro Corporation Company Information
Table 103. Nipro Corporation Description and Business Overview
Table 104. Nipro Corporation Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Nipro Corporation Blood-Gas Exchanger Product
Table 106. Nipro Corporation Recent Developments/Updates
Table 107. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
Table 108. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
Table 109. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood-Gas Exchanger Product
Table 111. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
Table 112. Spectrum Medical S.r.l. Company Information
Table 113. Spectrum Medical S.r.l. Description and Business Overview
Table 114. Spectrum Medical S.r.l. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Spectrum Medical S.r.l. Blood-Gas Exchanger Product
Table 116. Spectrum Medical S.r.l. Recent Developments/Updates
Table 117. Dongguan Kewei Medical Instrument Co., Ltd. Company Information
Table 118. Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
Table 119. Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Dongguan Kewei Medical Instrument Co., Ltd. Blood-Gas Exchanger Product
Table 121. Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
Table 122. Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
Table 123. Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
Table 124. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood-Gas Exchanger Product
Table 126. Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
Table 127. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
Table 128. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
Table 129. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood-Gas Exchanger Product
Table 131. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Blood-Gas Exchanger Distributors List
Table 135. Blood-Gas Exchanger Customers List
Table 136. Blood-Gas Exchanger Market Trends
Table 137. Blood-Gas Exchanger Market Drivers
Table 138. Blood-Gas Exchanger Market Challenges
Table 139. Blood-Gas Exchanger Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood-Gas Exchanger
Figure 2. Global Blood-Gas Exchanger Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Blood-Gas Exchanger Market Share by Type: 2025 & 2032
Figure 4. Cardiopulmonary Bypass Oxygenators Product Picture
Figure 5. Extracorporeal Membrane Oxygenation Oxygenators Product Picture
Figure 6. Others Product Picture
Figure 7. Global Blood-Gas Exchanger Market Value by Support Duration (US$ Million), 2021–2032
Figure 8. Global Blood-Gas Exchanger Market Share by Support Duration: 2025 vs 2032
Figure 9. Short-Term Oxygenators Up to 6 Hours Product Picture
Figure 10. Long-Term Oxygenators Over 6 Hours Product Picture
Figure 11. Global Blood-Gas Exchanger Market Value by Membrane Material (US$ Million), 2021–2032
Figure 12. Global Blood-Gas Exchanger Market Share by Membrane Material: 2025 vs 2032
Figure 13. Microporous Polypropylene Oxygenators Product Picture
Figure 14. Polymethylpentene Oxygenators Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood-Gas Exchanger Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Blood-Gas Exchanger Market Share by Application: 2025 & 2032
Figure 18. Adult Oxygenators
Figure 19. Pediatric and Neonatal Oxygenators
Figure 20. Global Blood-Gas Exchanger Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Blood-Gas Exchanger Market Size (US$ Million), 2021–2032
Figure 22. Global Blood-Gas Exchanger Sales (Units), 2021–2032
Figure 23. Global Blood-Gas Exchanger Average Price (US$/Unit), 2021–2032
Figure 24. Blood-Gas Exchanger Report Years Considered
Figure 25. Blood-Gas Exchanger Sales Share by Manufacturers in 2025
Figure 26. Global Blood-Gas Exchanger Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Blood-Gas Exchanger Players: Market Share by Revenue in Blood-Gas Exchanger in 2025
Figure 28. Blood-Gas Exchanger Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Blood-Gas Exchanger Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 31. North America Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 32. U.S. Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Canada Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Europe Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 35. Europe Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 36. Germany Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. France Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. U.K. Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Italy Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Russia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Asia Pacific Blood-Gas Exchanger Sales Market Share by Region (2021–2032)
Figure 42. Asia Pacific Blood-Gas Exchanger Revenue Market Share by Region (2021–2032)
Figure 43. China Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Japan Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. South Korea Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. India Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Australia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Taiwan Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Indonesia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Thailand Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Malaysia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Philippines Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 54. Latin America Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Blood-Gas Exchanger Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Blood-Gas Exchanger Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. U.A.E Blood-Gas Exchanger Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Blood-Gas Exchanger by Type (2021–2032)
Figure 64. Global Revenue Market Share of Blood-Gas Exchanger by Type (2021–2032)
Figure 65. Global Blood-Gas Exchanger Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Blood-Gas Exchanger by Application (2021–2032)
Figure 67. Global Revenue Market Share of Blood-Gas Exchanger by Application (2021–2032)
Figure 68. Global Blood-Gas Exchanger Price (US$/Unit) by Application (2021–2032)
Figure 69. Blood-Gas Exchanger Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232